Literature DB >> 25727079

Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox).

Vanessa S Reddy1, Quang T Bui2, Joan R Jacobs3, Susan M Begelman3, Dave P Miller4, William J French2.   

Abstract

Lipoprotein levels are currently recognized as independent risk factors for long-term cardiovascular events after acute myocardial infarction (AMI). During the acute-phase reaction after AMI, previous studies have reported trends of decreased low-density lipoprotein cholesterol (LDL-C), increased triglycerides, and variable high-density lipoprotein cholesterol (HDL-C) levels. However, the association between LDL-C and HDL-C levels and in-hospital mortality has not been well established following AMI. The relationship between lipid levels and in-hospital all-cause mortality in 115,492 patients hospitalized for AMI (July 2002 to December 2006), registered in the National Registry of Myocardial Infarction (NRMI) 4b-5, was evaluated using multivariable-adjusted logistic regression models. Mean LDL-C was 104 ± 38, HDL-C was 41 ± 14, and triglycerides 143 ± 83 mg/dl. Compared with the lowest quartile of LDL-C (<77 mg/dl), the risk of in-hospital mortality in the second to fourth quartiles was decreased (adjusted odds ratio 0.79, 0.80, and 0.85, respectively). For HDL-C, only those in the lowest quartile (<31 mg/dl) had higher risk of in-hospital mortality (odds ratio 1.20) compared with the highest quartile (≥47 mg/dl). Results from NRMI 4b-5 suggest a lipid paradox, with lower LDL-C levels associated with increased risk of in-hospital mortality, contrary to findings outside the acute setting. Consistent with previous analyses, lowest HDL-C levels were associated with increased in-hospital mortality. In conclusion, further explorations of the relationship between very low levels of LDL-C, myocardial necrosis, and subsequent adverse cardiovascular events are warranted.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25727079     DOI: 10.1016/j.amjcard.2014.12.006

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  34 in total

1.  Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised.

Authors:  Shaozhuang Dong; Wenjie Ji; Shan Zeng; Jun Miao; Lifang Yan; Xinlin Liu; Junxiang Liu; Xin Zhou; Qing Yang
Journal:  J Cardiovasc Transl Res       Date:  2020-06-18       Impact factor: 4.132

2.  Paradoxical impact of decreased low-density lipoprotein cholesterol level at baseline on the long-term prognosis in patients with acute coronary syndrome.

Authors:  Takuya Nakahashi; Hayato Tada; Kenji Sakata; Yohei Yakuta; Yoshihiro Tanaka; Akihiro Nomura; Tadatsugu Gamou; Hidenobu Terai; Yuki Horita; Masatoshi Ikeda; Masanobu Namura; Masayuki Takamura; Kenshi Hayashi; Masakazu Yamagishi; Masa-Aki Kawashiri
Journal:  Heart Vessels       Date:  2017-12-29       Impact factor: 2.037

3.  The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats.

Authors:  Lilla Lenart; Judit Hodrea; Adam Hosszu; Sandor Koszegi; Dora Zelena; Dora Balogh; Edgar Szkibinszkij; Apor Veres-Szekely; Laszlo Wagner; Adam Vannay; Attila J Szabo; Andrea Fekete
Journal:  Psychopharmacology (Berl)       Date:  2016-01-26       Impact factor: 4.530

4.  Association of low-density lipoprotein pattern with mortality after myocardial infarction: Insights from the TRIUMPH study.

Authors:  Yashashwi Pokharel; Yuanyuan Tang; Bhaskar Bhardwaj; Krishna K Patel; Mohammed Qintar; James H O'Keefe; Krishnaji R Kulkarni; Peter H Jones; Seth S Martin; Salim S Virani; John A Spertus
Journal:  J Clin Lipidol       Date:  2017-10-03       Impact factor: 4.766

5.  Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH Registry.

Authors:  Seth S Martin; Kamil F Faridi; Parag H Joshi; Michael J Blaha; Krishnaji R Kulkarni; Arif A Khokhar; Thomas M Maddox; Edward P Havranek; Peter P Toth; Fengming Tang; John A Spertus; Steven R Jones
Journal:  Clin Cardiol       Date:  2015-10-13       Impact factor: 2.882

6.  Association between baseline LDL-C and prognosis among patients with coronary artery disease and advanced kidney disease.

Authors:  Bo Wang; Shiqun Chen; Jin Liu; Yan Liang; Liangguang Meng; Xiaoming Yan; Haozhang Huang; Guanzhong Chen; Zhidong Huang; Danyuan Xu; Min Li; Jingjing Liang; Shuangxin Liu; Jiyan Chen; Yong Liu; Ning Tan
Journal:  BMC Nephrol       Date:  2021-05-06       Impact factor: 2.388

7.  Hyperlipidaemia and mortality among patients hospitalised with pneumonia: retrospective cohort and propensity score matched study.

Authors:  Mohammed Yousufuddin; Umesh M Sharma; Sumit Bhagra; Mohammad Hassan Murad
Journal:  BMJ Open Respir Res       Date:  2021-03

Review 8.  Potential of lipoproteins as biomarkers in acute myocardial infarction.

Authors:  Haseeb Ahmad Khan; Aishah Ekhzaimy; Isra Khan; Meena Kishore Sakharkar
Journal:  Anatol J Cardiol       Date:  2017-07       Impact factor: 1.596

9.  The Association between Nutritional Status and In-Hospital Mortality among Patients with Heart Failure-A Result of the Retrospective Nutritional Status Heart Study 2 (NSHS2).

Authors:  Michał Czapla; Raúl Juárez-Vela; Katarzyna Łokieć; Piotr Karniej
Journal:  Nutrients       Date:  2021-05-14       Impact factor: 5.717

Review 10.  Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review.

Authors:  Uffe Ravnskov; David M Diamond; Rokura Hama; Tomohito Hamazaki; Björn Hammarskjöld; Niamh Hynes; Malcolm Kendrick; Peter H Langsjoen; Aseem Malhotra; Luca Mascitelli; Kilmer S McCully; Yoichi Ogushi; Harumi Okuyama; Paul J Rosch; Tore Schersten; Sherif Sultan; Ralf Sundberg
Journal:  BMJ Open       Date:  2016-06-12       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.